Guangdong Taiantang Pharmaceutical Co., Ltd. (002433.SZ)

Guangdong Taiantang Pharmaceutical Co., Ltd. (002433.SZ) — VMCI valuation read

Across 120 indicators, Guangdong Taiantang Pharmaceutical Co., Ltd. (002433.SZ) lands at VMCI 30/100. The Healthcare sector median is 50, so the 20-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 002433.SZ in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 002433.SZ trades at 15.0x earnings, 17% below the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of -1.1x leaves covenant headroom for 002433.SZ on the trailing balance sheet.

002433.SZ rose 1.8% over the trailing 7 days, with a -20.7% read on a 30-day basis.